Detalles de la búsqueda
1.
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies.
Nat Immunol
; 21(11): 1346-1358, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32868929
2.
Single-organ pulmonary metastasis is a favorable prognostic factor in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors.
BMC Cancer
; 23(1): 634, 2023 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37415118
3.
PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer.
Proc Natl Acad Sci U S A
; 116(20): 9999-10008, 2019 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31028147
4.
Vescimonas gen. nov., Vescimonas coprocola sp. nov., Vescimonas fastidiosa sp. nov., Pusillimonas gen. nov. and Pusillimonas faecalis sp. nov. isolated from human faeces.
Int J Syst Evol Microbiol
; 71(11)2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34726590
5.
Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial.
Lancet Oncol
; 21(8): 1057-1065, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32589866
6.
Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study.
Int J Clin Oncol
; 25(4): 614-621, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31838590
7.
Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (Edition 1.0).
Cancer Sci
; 109(9): 2980-2985, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30187675
8.
Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study.
Oncologist
; 23(1): 7-15, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28894015
9.
A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites.
BMC Cancer
; 18(1): 120, 2018 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-29385993
10.
Corrigendum: Vescimonas gen. nov., Vescimonas coprocola sp. nov., Vescimonas fastidiosa sp. nov., Pusillimonas gen. nov. and Pusillimonas faecalis sp. nov. isolated from human faeces.
Int J Syst Evol Microbiol
; 72(4)2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35442879
11.
Clinical outcomes in 66 patients with advanced gastric cancer treated in phase I trials: the NCCHE experience.
Invest New Drugs
; 33(3): 664-70, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25773493
12.
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer.
BMC Cancer
; 15: 258, 2015 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25886136
13.
[Efficacy of TAS-102].
Gan To Kagaku Ryoho
; 42(1): 1-5, 2015 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-25596673
14.
RNA synthesis in liposomes with negatively charged lipids after fusion via freezing-thawing.
Genes Genet Syst
; 992024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38382922
15.
Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancer.
J Immunother Cancer
; 12(2)2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38336371
16.
[A case of blastic plasmacytoid dendritic cell neoplasm involving the skin].
Gan To Kagaku Ryoho
; 40(9): 1255-8, 2013 Sep.
Artículo
en Japonés
| MEDLINE | ID: mdl-24047792
17.
Renal impairment as a risk factor for trifluridine/tipiracil-induced adverse events in metastatic colorectal cancer patients from the REGOTAS study.
Sci Rep
; 13(1): 17931, 2023 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37863951
18.
Efficacy and Safety of Trastuzumab Deruxtecan and Nivolumab as Third- or Later-Line Treatment for HER2-Positive Advanced Gastric Cancer: A Single-Institution Retrospective Study.
J Gastric Cancer
; 23(4): 609-621, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37932227
19.
p70S6K/Akt dual inhibitor DIACC3010 is efficacious in preclinical models of gastric cancer alone and in combination with trastuzumab.
Sci Rep
; 13(1): 16017, 2023 09 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37749105
20.
A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer.
Transl Oncol
; 35: 101718, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37364334